Sign In
Buy AVNS
$24.99
+0 (+0%)
At Close: Jul 31, 2026
Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
08:25pm, Wednesday, 07'th Jan 2026
ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P.
New Strong Sell Stocks for January 6th
06:16am, Tuesday, 06'th Jan 2026
AVNS, ALG and CLMB have been added to the Zacks Rank #5 (Strong Sell) List on January 6th, 2026.
DexCom (NASDAQ:DXCM) & Avanos Medical (NYSE:AVNS) Head-To-Head Contrast
01:48am, Tuesday, 30'th Dec 2025
Avanos Medical (NYSE: AVNS - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the
93,572 Shares in Avanos Medical, Inc. $AVNS Bought by Squarepoint Ops LLC
05:14am, Sunday, 21'st Dec 2025
Squarepoint Ops LLC purchased a new stake in Avanos Medical, Inc. (NYSE: AVNS) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Co
New Strong Sell Stocks for Dec. 17
07:11am, Wednesday, 17'th Dec 2025
AVNS, ADM and OZK have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 17, 2025.
Why Is Avanos Medical (AVNS) Down 0.5% Since Last Earnings Report?
12:36pm, Friday, 05'th Dec 2025
Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Envestnet Asset Management Inc. Has $2.57 Million Stock Position in Avanos Medical, Inc. $AVNS
04:34am, Monday, 17'th Nov 2025
Envestnet Asset Management Inc. raised its position in shares of Avanos Medical, Inc. (NYSE: AVNS) by 45.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 210,
Financial Contrast: Avanos Medical (NYSE:AVNS) versus Inspira Technologies OXY B.H.N. (NASDAQ:IINN)
03:44am, Saturday, 15'th Nov 2025
Inspira Technologies OXY B.H.N. (NASDAQ: IINN - Get Free Report) and Avanos Medical (NYSE: AVNS - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare
Avanos Medical Gains on Q3 Earnings Beat, Raises '25 Sales View
09:35am, Thursday, 06'th Nov 2025
Avanos Medical posts a Q3 earnings and sales beat, boosts 2025 outlook as Specialty Nutrition drives solid double-digit growth.
Avanos Medical, Inc. (AVNS) Q3 2025 Earnings Call Transcript
04:41pm, Wednesday, 05'th Nov 2025
Avanos Medical, Inc. ( AVNS ) Q3 2025 Earnings Call November 5, 2025 9:00 AM EST Company Participants Jason Pickett - Vice President of Tax & Treasurer David Pacitti - CEO & Director Scott Galovan - C
Avanos Medical (AVNS) Q3 Earnings and Revenues Beat Estimates
09:16am, Wednesday, 05'th Nov 2025
Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.36 per share a year ago.
Avanos Medical, Inc. Announces Third Quarter 2025 Results
07:00am, Wednesday, 05'th Nov 2025
Delivered double-digit growth in Specialty Nutrition Systems segment Closed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segment Raising and n
Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2025 Financial Results
10:31am, Monday, 27'th Oct 2025
ALPHARETTA, Ga. , Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on
WRS Group Announces Agreement to Acquire Avanos Medical's US Game Ready® Orthopedic Rental Business
08:00am, Thursday, 23'rd Oct 2025
ANN ARBOR, Mich. , Oct. 23, 2025 /PRNewswire/ -- WRS Group, LLC (WRS), a privately held company based in Ann Arbor, Michigan, announced today that it has entered into a definitive agreement with Avan
Janney Montgomery Scott LLC Sells 5,237 Shares of Avanos Medical, Inc. $AVNS
03:44am, Wednesday, 22'nd Oct 2025
Janney Montgomery Scott LLC reduced its holdings in Avanos Medical, Inc. (NYSE: AVNS) by 26.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commi
